Annual Shareholders Equity
-$4.43 M
-$12.56 M-154.50%
31 December 2023
Summary:
CNS Pharmaceuticals annual stockholders equity is currently -$4.43 million, with the most recent change of -$12.56 million (-154.50%) on 31 December 2023. During the last 3 years, it has fallen by -$18.38 million (-131.78%). CNSP annual shareholders equity is now -131.78% below its all-time high of $13.95 million, reached on 31 December 2020.CNSP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$3.35 M
+$7.65 M+178.08%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly stockholders equity is currently $3.35 million, with the most recent change of +$7.65 million (+178.08%) on 30 September 2024. Over the past year, it has increased by +$5.09 million (+292.57%). CNSP quarterly shareholders equity is now -77.35% below its all-time high of $14.80 million, reached on 31 March 2022.CNSP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -154.5% | +292.6% |
| 3 y3 years | -131.8% | -63.2% |
| 5 y5 years | -706.9% | +10000.0% |
CNSP Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -131.8% | at low | -77.3% | +175.6% |
| 5 y | 5 years | -131.8% | at low | -77.3% | +175.6% |
| alltime | all time | -131.8% | at low | -77.3% | +175.6% |
CNS Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.35 M(-178.1%) |
| June 2024 | - | -$4.29 M(-3.1%) |
| Mar 2024 | - | -$4.43 M(-0.0%) |
| Dec 2023 | -$4.43 M(-154.5%) | -$4.43 M(+154.6%) |
| Sept 2023 | - | -$1.74 M(-170.9%) |
| June 2023 | - | $2.45 M(-29.7%) |
| Mar 2023 | - | $3.49 M(-57.1%) |
| Dec 2022 | $8.13 M(+32.0%) | $8.13 M(-3.1%) |
| Sept 2022 | - | $8.39 M(-27.2%) |
| June 2022 | - | $11.52 M(-22.2%) |
| Mar 2022 | - | $14.80 M(+140.2%) |
| Dec 2021 | $6.16 M | $6.16 M(-32.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $9.10 M(-26.7%) |
| June 2021 | - | $12.41 M(+10.4%) |
| Mar 2021 | - | $11.24 M(-19.4%) |
| Dec 2020 | $13.95 M(+83.5%) | $13.95 M(+463.7%) |
| Sept 2020 | - | $2.47 M(-33.6%) |
| June 2020 | - | $3.72 M(-36.6%) |
| Mar 2020 | - | $5.88 M(-22.7%) |
| Dec 2019 | $7.60 M(-1483.8%) | $7.60 M(>+9900.0%) |
| Sept 2019 | - | $200.00(-99.9%) |
| June 2019 | - | $377.70 K(-168.8%) |
| Dec 2018 | -$549.30 K(+839.0%) | -$549.30 K |
| Dec 2017 | -$58.50 K | - |
FAQ
- What is CNS Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual shareholders equity year-on-year change?
- What is CNS Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly shareholders equity year-on-year change?
What is CNS Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of CNSP is -$4.43 M
What is the all time high annual shareholders equity for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual stockholders equity is $13.95 M
What is CNS Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, CNSP annual stockholders equity has changed by -$12.56 M (-154.50%)
What is CNS Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of CNSP is $3.35 M
What is the all time high quarterly shareholders equity for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly stockholders equity is $14.80 M
What is CNS Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, CNSP quarterly stockholders equity has changed by +$5.09 M (+292.57%)